Siva Sai Chandragiri

Mr. Siva Sai Chandragiri

AMITY INSTITUTE OF PHARMACY, AMITY UNIVERSITY UTTAR PRADESH LUCKNOW CAMPUS, INDIA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2022 in Phytomedicine
Verified
Journal Article
Open access
RSRajeev K. Singla
Rajeev K. Singla
RDRonita De
Ronita De
Thomas EfferthThomas Efferth
Thomas Efferth
BMBruno Mezzetti
Bruno Mezzetti
SUSahab Uddin
Sahab Uddin
BSBairong Shen
Bairong Shen
The development of digital technologies and the evolution of open innovation approaches have enabled the creation of diverse virtual organizations and enterprises coordinating their activities primarily online. The open innovation platform titled "International Natural Product Sciences Taskforce" (INPST) was established in 2018, to bring together in collaborative environment individuals and organizations interested in natural product scientific research, and to empower their interactions by using digital communication tools. In this work, we present a general overview of INPST activities and showcase the specific use of Twitter as a powerful networking tool that was used to host a one-week "2021 INPST Twitter Networking Event" (spanning from 31st May 2021 to 6th June 2021) based on the application of the Twitter hashtag #INPST. The use of this hashtag during the networking event period was analyzed with Symplur Signals (https://www.symplur.com/), revealing a total of 6,036 tweets, shared by 686 users, which generated a total of 65,004,773 impressions (views of the respective tweets). This networking event's achieved high visibility and participation rate showcases a convincing example of how this social media platform can be used as a highly effective tool to host virtual Twitter-based international biomedical research events.

1 April 2025 in Aging Cell
Verified
Journal Article
Open access
BCBoglarka Csik
Boglarka Csik
ÁNÁdám Nyúl‐Tóth
Ádám Nyúl‐Tóth
RGRafal Gulej
Rafal Gulej
RPRoland Patai
Roland Patai
TKTamas Kiss
Tamas Kiss
ACAnna Csiszar
Anna Csiszar
With advancing age, neurovascular dysfunction manifests as impaired neurovascular coupling (NVC), microvascular rarefaction, and blood–brain barrier (BBB) disruption, contributing to vascular cognitive impairment (VCI). Our previous research established a causal link between vascular senescence induced cerebromicrovascular dysfunction and cognitive decline in accelerated aging models. The present study examines whether chronological aging promotes endothelial senescence, adversely affecting neurovascular health, and whether senolytic therapies can enhance neurovascular function and cognitive performance in aged mice. We used transgenic p16‐3MR mice to identify and eliminate senescent cells and employed genetic (ganciclovir) and pharmacological (ABT263/Navitoclax) senolytic approaches. Evaluations included spatial memory performance, NVC responses, cortical microvascular density, BBB permeability, and detection of senescent endothelial cells via flow cytometry. Brain endothelial cells exhibited heightened sensitivity to aging‐induced senescence, undergoing senescence at a greater rate and earlier than other brain cell types, particularly during middle age. This microvascular endothelial cell senescence was associated with NVC dysfunction, microvascular rarefaction, BBB disruption, and deteriorating cognitive performance. On the other hand, senolytic treatments in aged mice improved NVC responses, BBB integrity, microvascular density, and learning capabilities. Notably, these findings suggest that the most effective time window for senolytic treatment is in middle‐aged mice, where early intervention could better prevent neurovascular dysfunction and mitigate age‐related cognitive impairment.

5 November 2021 in Frontiers in Cell and Developmental Biology
Verified
Journal Article
Open access
RSRajeev K. Singla
Rajeev K. Singla
SCSiva Sai Chandragiri
Siva Sai Chandragiri
HCHitesh Chopra
Hitesh Chopra
SBSahar Behzad
Sahar Behzad
HBHimangini Bansal
Himangini Bansal
BSBairong Shen
Bairong Shen
Prostate cancer is the most common type of cancer among men and the second most frequent cause of cancer-related mortality around the world. The progression of advanced prostate cancer to castration-resistant prostate cancer (CRPC) plays a major role in disease-associated morbidity and mortality, posing a significant therapeutic challenge. Resistance has been associated with the activation of androgen receptors via several mechanisms, including alternative dehydroepiandrosterone biosynthetic pathways, other androgen receptor activator molecules, oncogenes, and carcinogenic signaling pathways. Tumor microenvironment plays a critical role not only in the cancer progression but also in the drug resistance. Numerous natural products have shown major potential against particular or multiple resistance pathways as shown by in vitro and in vivo studies. However, their efficacy in clinical trials has been undermined by their unfavorable pharmacological properties (hydrophobic molecules, instability, low pharmacokinetic profile, poor water solubility, and high excretion rate). Nanoparticle formulations can provide a way out of the stalemate, employing targeted drug delivery, improved pharmacokinetic drug profile, and transportation of diagnostic and therapeutic agents via otherwise impermeable biological barriers. This review compiles the available evidence regarding the use of natural products for the management of CRPC with a focus on nanoparticle formulations. PubMed and Google Scholar search engines were used for preclinical studies, while ClinicalTrials.gov and PubMed were searched for clinical studies. The results of our study suggest the efficacy of natural compounds such as curcumin, resveratrol, apigenin, quercetin, fisetin, luteolin, kaempferol, genistein, berberine, ursolic acid, eugenol, gingerol, and ellagic acid against several mechanisms leading to castration resistance in preclinical studies, but fail to set the disease under control in clinical studies. Nanoparticle formulations of curcumin and quercetin seem to increase their potential in clinical settings. Using nanoparticles based on betulinic acid, capsaicin, sintokamide A, niphatenones A and B, as well as atraric acid seems promising but needs to be verified with preclinical and clinical studies.

11 December 2023 in Microcirculation
Verified
Journal Article
Closed access
RGRafał Gulej
Rafał Gulej
BCBoglarka Csik
Boglarka Csik
JFJanet Faakye
Janet Faakye
STStefano Tarantini
Stefano Tarantini
SSSantny Shanmugarama
Santny Shanmugarama
ÁNÁdám Nyúl‐Tóth
Ádám Nyúl‐Tóth

1 January 2021 in Current Research in Biotechnology
Verified
Journal Article
Open access
MKMaria Kletecka-Pulker
Maria Kletecka-Pulker
Himel MondalHimel Mondal
Himel Mondal
Dongdong WangDongdong Wang
Dongdong Wang
RPR. Gonzalo Parra
R. Gonzalo Parra
AMAbdulkadir Yusif Maigoro
Abdulkadir Yusif Maigoro
Atanas G. AtanasovAtanas G. Atanasov
Atanas G. Atanasov

22 April 2024
Verified
Journal Article
Open access
PDF file
AYAndy Wai Kan Yeung
Andy Wai Kan Yeung
OLOlena Litvinova
Olena Litvinova
Nicola Luigi BragazziNicola Luigi Bragazzi
Nicola Luigi Bragazzi
Yousef KhaderYousef Khader
Yousef Khader
Md.Mostafizur RahmanMd.Mostafizur Rahman
Md.Mostafizur Rahman
Atanas G. AtanasovAtanas G. Atanasov
Atanas G. Atanasov
Aim: This study aimed to identify and analyze the top 100 most cited digital health and mobile health (m-health) publications. It could aid researchers in the identification of promising new research avenues, additionally supporting the establishment of international scientific collaboration between interdisciplinary research groups with demonstrated achievements in the area of interest. Methods: On 30th August, 2023, the Web of Science Core Collection (WOSCC) electronic database was queried to identify the top 100 most cited digital health papers with a comprehensive search string. From the initial search, 106 papers were identified. After screening for relevance, six papers were excluded, resulting in the final list of the top 100 papers. The basic bibliographic data was directly extracted from WOSCC using its “Analyze” and “Create Citation Report” functions. The complete records of the top 100 papers were downloaded and imported into a bibliometric software called VOSviewer (version 1.6.19) to generate an author keyword map and author collaboration map. Results: The top 100 papers on digital health received a total of 49,653 citations. Over half of them (n = 55) were published during 2013–2017. Among these 100 papers, 59 were original articles, 36 were reviews, 4 were editorial materials, and 1 was a proceeding paper. All papers were written in English. The University of London and the University of California system were the most represented affiliations. The USA and the UK were the most represented countries. The Journal of Medical Internet Research was the most represented journal. Several diseases and health conditions were identified as a focus of these works, including anxiety, depression, diabetes mellitus, cardiovascular diseases, and coronavirus disease 2019 (COVID-19). Conclusions: The findings underscore key areas of focus in the field and prominent contributors, providing a roadmap for future research in digital and m-health.